来源:蜘蛛抓取(WebSpider)
时间:2023-10-21 18:50
标签:
selpercatinib 医保
(EL-rah-NA-tah-mab)Elranatamab-bcmm is a type of
targeted therapy called a bispecific T-cell engager (BiTE). It is an antibody therapy that binds to two target proteins on different cells. Elranatamab-bcmm binds to a protein called CD3 on healthy T cells (immune cells that help kill cancer cells) and to a protein called BCMA on myeloma cells. This brings healthy T cells and the myeloma cells close together so the T cells can more effectively kill them.US Brand Name(s)ElrexfioFDA ApprovedYes